a Division of Pediatric Clinical Pharmacology and Allergy/Immunology, National Jewish Medical and Research Center, and the Departments of Pediatrics and Pharmacology, University of Colorado Health Sciences Center, Denver, Colo
b Allergy Associates PC, Portland, Ore
c AstraZeneca LP, Wilmington, Del
E-mail: [email protected].
Supported by AstraZeneca LP, Wilmington, Del.
Disclosure of potential conflict of interest: S. J. Szefler has consulting arrangements with AstraZeneca, GlaxoSmithKline, Aventis, Genentech, and Merck and has received research support from the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the National Heart, Lung, and Blood Institute. J. W. Baker and his wife have done clinical trials for Aventis, Centocor, GlaxoSmithKline, AstraZeneca, Genentech, Novartis, Abbott, Medicis, Galderma, Schering-Plough, Merck, Lev Pharma, Seprecor, Wyeth, Aperon, ALK, MedPointe, Skypharma, Amgen, J&J, Allergy Therapeutics, Altana, Amphistar, Ivax, and Mapp Pharmaceutical. T. Uryniak, M. Goldman, and P. E. Silkoff are employed by AstraZeneca.
Available online March 6, 2008.
